Results 131 to 140 of about 3,671 (174)

Testosterone replacement therapy and bladder cancer. [PDF]

open access: yesCan Urol Assoc J
Kanaan MF   +4 more
europepmc   +1 more source

Management of prolonged post-operative pelvic pain after transurethral prostate surgery: a clinical real-world survey and international comparison of therapy regimens. [PDF]

open access: yesBMC Urol
Traeger M   +10 more
europepmc   +1 more source

Paradoxical Nonscarring Alopecia Following Mesotherapy with Dutasteride: A Case Series.

open access: yesInt J Trichology
Chandrashekhar M   +3 more
europepmc   +1 more source

The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption

open access: closedCurrent Sexual Health Reports, 2018
Post-finasteride syndrome (PFS) is a disorder characterized by a set of clinical symptoms experienced during use or after drug discontinuation. This cluster of symptoms encompasses overall sexual dysfunction (SD), erectile dysfunction (ED), loss of libido, depression, suicidal ideation, anxiety, panic attacks, insomnia, and cognitive dysfunction.
Abdulmaged M. Traish
exaly   +4 more sources

Post-Finasteride Syndrome. Literature Review

Archivos Españoles de Urología, 2022
Post-finasteride syndrome (PFS) is a little known adverse effect of 5α-reductase inhibitor (5-ARI) drugs used in benign prostatic hyperplasia (BPH) and androgenetic alopecia. Five articles on the syndrome have been published in Spain, although no review has been published.The objectives of this article are to review the world literature, including the ...
openaire   +4 more sources

Home - About - Disclaimer - Privacy